Skip to content

Apelin estimation in periodontitis patients with obesity and type 2 diabetes

A comparative evaluation of serum and salivary levels of apelin in chronic periodontitis associated with obesity and type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017522
Enrollment
84
Registered
2019-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Control Intervention1: Apelin: Apelin, a novel bioactive peptide, was found to be positively correlated with obesity and type 2 diabetes mellitus. It plays a certain role in inflammation-related disea

Sponsors

Panineeya institute of dental sciences and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with BMI 30.0 â?? 39.0 kg/m2 for group 2. (Centers for Disease Control and Prevention) Patients previously diagnosed with T2DM and under medication were confirmed by their glycated haemoglobin (HbA1c: 6.5% - 8.5 --ADA,2017) Patients with at least 15 natural teeth remaining. Patients suffering from chronic periodontitis (>= 5mm pocket depth or >= 3mm loss of attachment) were selected. (Update to 1999 Disease Classification-AAP) Patients who have not received periodontal therapy, within preceding six months.

Exclusion criteria

Exclusion criteria: Patients having aggressive periodontitis. Patients having any other systemic diseases. Patients with BMI > 40 kg/m2. Patients with HbA1c > 8.5%. Patients taking high-dose steroid therapy, radiation or immunosuppressive therapy. Pregnant and lactating woman. History of smoking within the past five years. Mentally retarded and un-cooperative patients

Design outcomes

Primary

MeasureTime frame
serum and salivary apelin levelsTimepoint: baseline

Secondary

MeasureTime frame
no secondary outcomesTimepoint: not applicable

Countries

India

Contacts

Public ContactDuddukuri Hema

Panineeya institute of dental sciences and research centre

surya.prasanna@yahoo.com9440387830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026